36 / 76
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 6, November/December 2016
366
AFRICA
Reducing risks, promoting healthy life. Geneva; World Health
Organization.
15. Orth SR, Stockman A, Conradt C, Ritz E, Ferro M, Kreusser W,
et al
.
Smoking as a risk factor for end-stage renal failure in men with primary
renal disease.
Kidney Int
1998;
54
: 926–931.
16. Physical activity. Guidelines for Americans. Office of Disease Prevention
& Health Promotion, US Department of Health and Human Services,
October 2008 (www.health.gov/paguidelines).
17. Surawicz B. Electrocardiographic diagnosis of chamber enlargement.
J
Am Coll Cardiol
1986;
8
: 711–724.
18. K/DOQI clinical practical guidelines for chronic kidney disease (CKD):
Evaluation, classification and stratification. Kidney Disease Outcome
Quality Initiative.
Am J Kidney Dis
2002;
39
(2Suppl): S22–26.
19. Longo AL, Lepira FB, Sumaili EK, Makulo JR, Mukumbi H, Bukabau
JB,
et al
. Prevalence of low estimated glomerular filtration rate, protein-
uria, and associated risk factors among HIV-infected black patients
using Cockroft-Gault and modification of diet in renal disease study
equations.
J Acquir Immune Defic Syndr
2012;
59
(1): 59–64. doi: 10.1097/
QAI.0b013e31823587b0.
20. Benetos A, Salvi P, Lacolley P. Blood pressure regulation during the
aging process: the end of the “hypertension era”?
J Hypertens
2011;
29
(4): 646–652.
21. Cowart JB, Taylor AA. Should two-drug initial therapy for hyperten-
sion be recommended for all patients?
Curr Hypertens Rep
2012;
14
(4):
324–332. doi: 10.1007/s11906-012-0280-9. Review.
22. Rayner B, Schoeman HS. A cross-sectional study of blood pressure
control in hypertensive patients in general practice (the I-TARGET
study).
Cardiovasc J Afr
2009;
20
(4): 224–227.
23. Dennison CR, Peer N, Lombard CJ, Kepe L, Levitt NS, Steyn K, Hill
MN. Cardiovascular risk and comorbid conditions among black South
Africans with hypertension in public and private primary care settings:
the HiHi study.
Ethn Dis
2007;
17
(3): 477–483.
24. Omuemu VO, Okojie HO, Omuemu CE. Awareness of high blood
pressure status, treatment and control in rural community in Edo State.
Niger J Clin Pract
2007;
10
(3): 208–212.
25. Yaméogo NV, Kagambèga LJ, Millogo RCG, Kologo KJ, Yaméogo AA,
Mandi GD,
et al.
Factors associated with poor blood pressure control
in hypertensive black patients: cross-sectional study of 456 patients from
Burkina Faso.
Ann Cardiol Angéiol
2013;
62
(1): 38–42.
26. Kramoh EK, N’goran YN, Aké-Traboulsi E, Anzouan-Kacou JB,
Konin CK, Coulibaly I,
et al
. Hypertension management in an outpa-
tient clinic at the Institute of Cardiology of Abidjan (Ivory Coast).
Arch
Cardiovasc Dis
2011;
104
(11): 558–564. doi: 10.1016/j.acvd.2011.08.002.
Epub 2011 Oct 28.
27. Ayodele OE, Alebiosu CO, Salako BL. Differential control of systolic
and diastolic blood pressure in blacks with essential hypertension.
J Natl
Med Assoc
2004;
96
(3): 310–314.
28. Sani MU, Mijinyawa MS, Adamu B, Abdu A, Borodo MM. Blood pres-
sure control among treated hypertensives in a tertiary health institution.
Niger J Med
2008;
17
(3): 270–274.
29. Dzudie A, Kengne AP, Muna WF, Ba H, Menanga A, Kouam KC,
et
al
. Prevalence, awareness, treatment and control of hypertension in a
self-selected sub-Saharan African urban population: a cross-sectional
study.
Br Med J Open
2012;
24
: 2(4), pii: e001217. Doi: 10.136/bmjo-
pen-2012-001217.
30. Hendriks ME, Wit FW, Roos MT, Brewster LM, Akande TM, de Beer
IH,
et al
. Hypertension in sub-Saharan Africa: cross-sectional surveys
in four rural and urban communities.
PLoS One
2012;
7
(3): e32638. doi:
10.1371/journal.pone.0032638. Epub 2012 Mar 12.
31. Hyman DJ, Pavlik VN. Barriers to blood pressure control. In:
Hypertension Primer, the Essentials of High Blood Pressure.
4th edn.
Wolters Kluwer/Lippincott Williams and Wilkins, 2008: 418–420.
32. Redon J, Erdine S, Böhm M, Ferri C, Kolloch R, Kreutz R,
et
al.
Physician attitudes to blood pressure control: findings from the
supporting hypertension awareness and research Europe-Wide Survey.
J
Hypertens
2011;
29
: 1633–1640.
33. Saradon-Eck A, Egrot M, Blance MA, Faure M. Anthropological
approach of adherence factors for antihypertensive drugs.
Health Policy
2010;
5
(4): e157–175.
34. Krousel-Wood M, Joyce C, Holt E, Muntner P, Webber LS, Morisky
DE,
et al
. Predictors of decline in medication adherence: results from the
cohort study of medication adherence among older adults.
Hypertension
2011;
58
(5): 804–810.
35. Bohen SD, Samuels TA, Yeh C, Marinopoulos SS, Mc Guire M, Abuid
M,
et al
. Failure to intensify antihypertensive treatment by primary care
providers: a color study in adults with diabetes mellitus and hyperten-
sion.
J Gen Intern Med
2008;
23
(5): 543–560.
36. Schimtt KE, Edie CF, Laflam P, Simbartl LA, Thaker CV. Adherence
to antihypertensive agents and blood pressure control in chronic kidney
disease.
Am J Nephrol
2010;
32
(6): 541–548.
37. Adedapo AD, Sikuade O, Adeleke S, Okechukwu R. Drug utilization
and blood pressure control in a population where antihypertensive
are given free: effect of policy change.
Afr J Med Med Sci
2012;
41
(4):
349–356.
38. Zidek W, Naditch-Brûlé L, Perlini S, Farsang C, Kjeldsen SE. Blood
pressure and components of the metabolic syndrome: the Good Survey.
Cardiovasc Diabetol
2009;
8
: 51.
39. Cortez-Dias N, Martins SR, Belo A, Fiuza M. Association of metabolic
risk factors with uncontrolled hypertension: comparison of the several
definitions of metabolic syndrome.
J Hypertens
2013, Jun 27. [Epub
ahead of print].
40. Maseko MJ, Woodiwiss AJ, Majane OH, Molebatsi N, Norton GR.
Marked underestimation of blood pressure control with conventional
vs ambulatory measurements in an urban, developing community of
African ancestry.
Am J Hypertens
2011;
24
(7): 789–795.